Premium
P69: FIRST IN CLASS: REAL WORLD EXPERIENCE WITH DUPIXENT (DUPILUMAB), A MONOCLONAL ANTIBODY TARGETING IL‐4RA IN SEVERE ATOPIC DERMATITIS
Publication year - 2021
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.19_15529
Subject(s) - dupilumab , medicine , atopic dermatitis , monoclonal antibody , immunology , monoclonal , dermatology , antibody